Spray-on plasters

SPRAY-ON "sticking plasters" can now help heal the wounds inside the body made during delicate keyhole surgery. The bright blue plasters, sprayed directly onto organs in the form of a gel, promise to prevent post-surgical complications that usually mean another operation.

"It's like an internal wound dressing," says Amarpreet Sawhney, founder of Confluent Surgical of Waltham, Massachusetts, the company developing the gel. Sawhney described the gel last week at BioPartnering, a London biotechnology conference

Although similar dressings are already available as biodegradable sheets (New Scientist, 10 May 1995, p 23), he says surgeons can only apply these during standard, open surgery-and they sometimes don't stay in place. But you can spray on the gel during keyhole surgery, and it will stay put.

The dressings protect the surfaces of organs and wounds, preventing them from sticking to neighbouring organs and tissues to form post-surgical adhesions. These painful scars happen after routine gynaecological, heart, gut, brain and general surgery. Corrective operations cost an estimated $3 billion worldwide each year, says Sawhney.

The gel starts off as two separate liquids. When they're sprayed together onto an organ, they congeal into a bright blue gel which sticks to the surface of the wound. It degrades harmlessly about a week later once the tissue underneath has healed.

The liquids are two variants of a polymer called polyethylene glycol. A double-barrelled dispenser turns solutions of both polymers into a fine mist which surgeons spray onto wounds. The liquids solidify into a gel within 2 seconds of contact with the wound.

"It's blue so the surgeon can see where it goes," says Sawhney. "It's really hard for them to screw up." The gel is undergoing clinical tests at hospitals in France, Germany and the US. "We've done 60 patients so far with no problems," Sawhney told New Scientist.

The gel

Contact: Claire Bowles
New Scientist

Page: 1 2

Related biology news :

1. Study: Emission of smog ingredients from trees is increasing rapidly
2. Study explores gene transfer to modify underlying course of Alzheimers disease
3. Study reveals why eyes in some paintings seem to follow viewers
4. Study by Israeli scientists provides insight on DNA code
5. Study reveals first genetic step necessary for prostate cancer growth
6. Study of flu patients reveals virus outsmarting key drug
7. Study in Science reveals recreational fishing takes big bite of ocean catch
8. Study suggests cell-cycle triggers might be cancer drug targets
9. Study narrows search for genes placing men at increased risk for prostate cancer
10. Study links high carbohydrate diet to increased breast cancer risk
11. Study explains spatial orientation differences between sexes

Post Your Comments:

(Date:4/5/2017)... LONDON , April 4, 2017 KEY ... is anticipated to expand at a CAGR of 25.76% ... neurodegenerative diseases is the primary factor for the growth ... full report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The ... of product, technology, application, and geography. The stem cell ...
(Date:3/30/2017)... 30, 2017 The research team of The ... (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery ... of speed and accuracy for use in identification, crime investigation, immigration ... ... A research team ...
(Date:3/27/2017)... , March 27, 2017  Catholic Health ... and Management Systems Society (HIMSS) Analytics for achieving ... Adoption Model sm . In addition, CHS previously ... U.S. hospitals using an electronic medical record (EMR). ... its high level of EMR usage in an ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity ... for performing systematic gain-of-function studies. , This complement to loss-of-function studies, such ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017  SkylineDx ... London (ICR) and University of Leeds ... to risk-stratify patients with multiple myeloma (MM), in a multi-centric ... The University of Leeds is the ... UK, and ICR will perform the testing services to include ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it ... Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... ... innovation and business process optimization firm for the life sciences and healthcare industries, ... conference in San Francisco. , The presentation, “Automating GxP Validation for Agile ...
Breaking Biology Technology:
Cached News: